Related topics

CytoSorbents: 2Q Earnings Snapshot

August 3, 2018

MONMOUTH JUNCTION, N.J. (AP) _ CytoSorbents Corp. (CTSO) on Thursday reported a loss of $5.8 million in its second quarter.

The Monmouth Junction, New Jersey-based company said it had a loss of 19 cents per share.

The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 13 cents per share.

The blood purification therapy company posted revenue of $5.8 million in the period, which topped Street forecasts. Four analysts surveyed by Zacks expected $5.1 million.

CytoSorbents shares have increased 98 percent since the beginning of the year. The stock has more than doubled in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CTSO at https://www.zacks.com/ap/CTSO

Update hourly